The Scandinavian AED and Mobile Bystander Activation Trial
Launched by KAROLINSKA INSTITUTET · Dec 13, 2016
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
Early defibrillation in out-of-hospital cardiac arrest is associated with high survival rates. If the operator at the dispatch center suspects an out-of-hospital cardiac arrest he or she will activate the mobile positioning system (MPS) wich is integrated in the operators computer environment.
After activation, the system will locate all CPR-trained volunteers nearby the suspected OHCA. By computer based 1:1 randomization lay volunteers will be alerted and dispatched in 50 % of all suspected OHCAs in where the system is triggered by the dispatchers. In the intervention group, the activatio...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All EMS-treated OHCAs within the Stockholm County, Copenhagen and VGR area and in whom the mobile positioning system is activated at the emergency dispatch center
- Exclusion Criteria:
- • Crew witnessed OHCAs
- • Patients \<8 years of age
- • OHCAs due to trauma, intoxication, or suicide
- • OHCAs not treated by the EMS due to ethical reasons or obvious signs of death.
- • No OHCA cases
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Gothenburg, , Sweden
Patients applied
Trial Officials
Mattias Ringh, MD, PhD
Principal Investigator
Karolinska Institutet
Jacob Hollenberg, MD, PhD
Principal Investigator
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials